Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Diana Giannarelli

Association of Systemic Inflammation Index and Body Mass Index With Survival in Patients With Renal Cell Cancer Treated With Nivolumab

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Crizotinib in MET Deregulated or ROS1 Rearranged Pretreated Non-Small-Cell Lung Cancer (METROS): A Phase II, Prospective, Multicentre, Two-Arms Trial

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program

Journal for ImmunoTherapy of Cancer

English

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Journal for ImmunoTherapy of Cancer

English

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

English

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results From a Real‐World Population

English

Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations

British Journal of Cancer

Cancer Research

Oncology

2018

English

Chronic Lymphocytic Leukemia and Prognostic Models: A Bridge Between Clinical and Biological Markers

American Journal of Hematology

Hematology

2017

English

Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series

British Journal of Cancer

Cancer Research

Oncology

2016

English

Reliability of Six Prognostic Models to Predict Time-To-First-Treatment in Patients With Chronic Lymphocytic Leukaemia in Early Phase

American Journal of Hematology

Hematology

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Diana Giannarelli

Association of Systemic Inflammation Index and Body Mass Index With Survival in Patients With Renal Cell Cancer Treated With Nivolumab

Crizotinib in MET Deregulated or ROS1 Rearranged Pretreated Non-Small-Cell Lung Cancer (METROS): A Phase II, Prospective, Multicentre, Two-Arms Trial

Real-World Efficacy and Safety of Nivolumab in Previously-Treated Metastatic Renal Cell Carcinoma, and Association Between Immune-Related Adverse Events and Survival: The Italian Expanded Access Program

Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results From a Real‐World Population

Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations

Chronic Lymphocytic Leukemia and Prognostic Models: A Bridge Between Clinical and Biological Markers

Cessation of Targeted Therapy After a Complete Response in BRAF-mutant Advanced Melanoma: A Case Series

Reliability of Six Prognostic Models to Predict Time-To-First-Treatment in Patients With Chronic Lymphocytic Leukaemia in Early Phase